FDA Approves Livalo, a New Statin
Links shared publicly online about this topic.
- 1,849total visits
FDA Approves Livalo, a New Statin
View full resource at webmd.com
Most Recently Shared on August 3, 2009 at 10:19 pm By:
Livalo, a New Statin, Gets FDA Nod: The FDA has approved Livalo (generic name: pitavastatin), a new cholesterol-.. http://bit.ly/9sag4
Also Shared By:
FDA ponders need for heart studies ahead of drug approvals; New VC fund takes shape for Scotland; - FierceBiotech
fiercebiotech.com — “@FierceBiotech: Amgen's AMG 145 cuts cholesterol by 66% in early-stage trial involving patients taking statins. Article | Follow @FierceBiotech @JohnCFierce: Merck: I paid $41 billion for Read more...” View full resource at fiercebiotech.com
Most Recently Shared on March 26, 2012 at 4:57 pm By:
Cary Byrd - eDrugSearch.com Pharma and Health Advocate
FDA ponders need for heart studies ahead of drug approvals; New VC fund takes shape for Scotland; - FierceBiotech http://t.co/bpFa4yK5
FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs
fda.gov — “The U.S. Food and Drug Administration (FDA) has approved important safety label changes for the class of cholesterol-lowering drugs known as statins.” View full resource at fda.gov
Most Recently Shared on February 28, 2012 at 6:31 pm By:
FDA updates labeling for cholesterol pills - new warning about memory loss, no regular liver enzyme test http://t.co/lVyIGIsf #pharma
Should FDA Hold 'Me-Too' Drugs To A Higher Standard? : Shots - Health Blog : NPR
npr.org — “An editorial in a leading medical journal argues that society loses when drugmakers make too many medicines that treat illness in nearly the same way. The authors suggest a higher standard for approval of new brand-name drugs once a a cheap generic in a class becomes available.” View full resource at npr.org
Most Recently Shared on February 15, 2011 at 10:51 pm By:
Scott Hensley Health Organization
Should FDA Hold 'Me-Too' Drugs To A Higher Standard? 8th statin, pitavastatin, cited in JAMA piece. http://n.pr/fTO3Rw
Celera seeks FDA premarketing approval for KIF6 Genotyping Assay
news-medical.net — “Celera Corporation today announced that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration (FDA) for its KIF6 Genotyping Assay, a new molecular In Vitro diagnostic (IVD) test designed to detect a marker for risk of coronary heart disease (CHD) independent of traditional risk factors and aid clinical evaluation when statin treatment is being considered.” View full resource at news-medical.net
Most Recently Shared on January 3, 2011 at 1:41 pm By:
Celera seeks FDA premarketing approval for KIF6 Genotyping Assay: Celera Corporation today announced that it has... http://bit.ly/fx5rpg
Medical News: FDA Won't Approve Statin-Fenofibrate Combo - in Cardiovascular, Dyslipidemia from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA said it won't approve a new combo capsule for dyslipidemia until it learns more about the safety and efficacy of the compound, a decision that may be linked to the FDA's review o” View full resource at medpagetoday.com
Most Recently Shared on October 23, 2010 at 11:06 pm By:
Kent Willyard Doctor, Family Medicine Doctor, and Physician
Too bad. Lots of patients could benefit from this. - FDA Won't Approve Statin-Fenofibrate Combo - from MedPage Today http://t.co/3RiXQTD
Abbott's SIMCOR (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths - QualityPoint Technologies
qualitypointtech.net — “Abbott has received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott's proprietary niacin extended-release and simvastatin, the most commonly used statin. SIMCOR is a prescription medication used along with diet i” View full resource at qualitypointtech.net
Most Recently Shared on August 6, 2010 at 2:36 pm By:
Abbott's SIMCOR® (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths: Abbott ... http://bit.ly/av13zh
FDA Approves New Cholesterol-Lowering Drug
medicalnewstoday.com — “The u.s. food and drug administration approved the 4 milligram maximum dose of livalo (pitavastatin), a drug intended to improve blood cholesterol levels in persons with elevated or abnormal blood” View full resource at medicalnewstoday.com
Most Recently Shared on August 18, 2009 at 10:22 am By:
MedicalNewsToday: FDA Approves New Cholesterol-Lowering Drug http://bit.ly/2hLqoG Full http://bit.ly/gnORp
FDA approves new statin
endocrinetoday.com — “A new statin designed to treat high cholesterol in patients with elevated or abnormal cholesterol levels has received approval from the FDA.” View full resource at endocrinetoday.com
Most Recently Shared on August 5, 2009 at 5:21 pm By:
#FDA approved #pitavastatin (Livalo, Kowa Pharmaceuticals) to treat high #cholesterol: http://tinyurl.com/lv5u6g
Medical News: FDA Approves New Cholesterol-Lowering Drug - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a seventh statin drug to lower cholesterol -- pitavastatin (Livalo).” View full resource at medpagetoday.com
Most Recently Shared on August 5, 2009 at 12:01 am By:
FDA Approves New Cholesterol-Lowering Drug http://ow.ly/15JRis
FDA approves pitavastatin
theheart.org — “Available in Japan since 2003, the newest statin joins six others on the US market.” View full resource at theheart.org
Most Recently Shared on August 4, 2009 at 4:17 pm By:
heartwire: FDA approves pitavastatin, a new cholesterol-lowering drug http://bit.ly/129mcX
Advertisement
Heart Health
@HeartsHealth
MedicalNewsToday: FDA Approves New Cholesterol-Lowering Drug http://bit.ly/2hLqoG Full http://bit.ly/gnORp
1 year ago...